UTMD Key Statistics, Chart & Performance
The current stock price of UTMD is 55.96 USD. In the past month the price increased by 1.97%. In the past year, price decreased by -8.79%.
UTMD Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| COO | COOPER COS INC/THE | 19.85 | 16.29B | ||
| SOLV | SOLVENTUM CORP | 13.34 | 13.74B | ||
| ALGN | ALIGN TECHNOLOGY INC | 16.15 | 11.20B | ||
| MMSI | MERIT MEDICAL SYSTEMS INC | 23.69 | 5.23B | ||
| LNTH | LANTHEUS HOLDINGS INC | 11.17 | 4.41B | ||
| HAE | HAEMONETICS CORP/MASS | 16.7 | 3.75B | ||
| ICUI | ICU MEDICAL INC | 17.92 | 3.52B | ||
| XRAY | DENTSPLY SIRONA INC | 7.23 | 2.28B | ||
| UFPT | UFP TECHNOLOGIES INC | 25.73 | 1.71B | ||
| NEOG | NEOGEN CORP | 23.3 | 1.52B | ||
| STAA | STAAR SURGICAL CO | N/A | 1.15B | ||
| EMBC | EMBECTA CORP | 4 | 695.10M |
Related stock screener links
About UTMD
Company Profile
Utah Medical Products, Inc. engages in the manufacturing, developing, and marketing of disposable and reusable medical devices. The company is headquartered in Midvale, Utah and currently employs 155 full-time employees. The firm has a particular interest in healthcare for women and their babies. The Company’s broad range of products includes those used in critical care areas and the labor and delivery departments of hospitals, as well as outpatient clinics and physicians’ offices. Its products include BT-CATH, CVX-RIPE, AROM-COT, MUC-X, CORDGUARD, DISPOSA-HOOD, DELTRAN PLUS, GESCO, PICC-NATE, LETZ System, Filshie Clip System, PATHFINDER PLUS, SUPRAPUBIC CATHETERIZATION, LIBERTY System, ENDOCURETTE, LUMIN, and BioPharm HP-PRT, among others. BT-CATH is a patented uterine balloon tamponade catheter for controlling severe postpartum hemorrhage. MUC-X is an aspiration device. The firm produces medical devices for blood pressure monitoring and blood management, electrosurgery, labor and delivery, neonatal intensive care, urological care and women’s pelvic health.
Company Info
UTAH MEDICAL PRODUCTS INC
7043 S 300 West
Midvale UTAH 84047 US
CEO: Kevin L. Cornwell
Employees: 155
Phone: 18015215301
UTAH MEDICAL PRODUCTS INC / UTMD FAQ
What does UTAH MEDICAL PRODUCTS INC do?
Utah Medical Products, Inc. engages in the manufacturing, developing, and marketing of disposable and reusable medical devices. The company is headquartered in Midvale, Utah and currently employs 155 full-time employees. The firm has a particular interest in healthcare for women and their babies. The Company’s broad range of products includes those used in critical care areas and the labor and delivery departments of hospitals, as well as outpatient clinics and physicians’ offices. Its products include BT-CATH, CVX-RIPE, AROM-COT, MUC-X, CORDGUARD, DISPOSA-HOOD, DELTRAN PLUS, GESCO, PICC-NATE, LETZ System, Filshie Clip System, PATHFINDER PLUS, SUPRAPUBIC CATHETERIZATION, LIBERTY System, ENDOCURETTE, LUMIN, and BioPharm HP-PRT, among others. BT-CATH is a patented uterine balloon tamponade catheter for controlling severe postpartum hemorrhage. MUC-X is an aspiration device. The firm produces medical devices for blood pressure monitoring and blood management, electrosurgery, labor and delivery, neonatal intensive care, urological care and women’s pelvic health.
What is the stock price of UTAH MEDICAL PRODUCTS INC today?
The current stock price of UTMD is 55.96 USD. The price decreased by -0.57% in the last trading session.
Does UTAH MEDICAL PRODUCTS INC pay dividends?
UTAH MEDICAL PRODUCTS INC (UTMD) has a dividend yield of 2.2%. The yearly dividend amount is currently 1.22.
What is the ChartMill technical and fundamental rating of UTMD stock?
UTMD has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
How is the valuation of UTAH MEDICAL PRODUCTS INC (UTMD) based on its PE ratio?
The PE ratio for UTAH MEDICAL PRODUCTS INC (UTMD) is 15.81. This is based on the reported non-GAAP earnings per share of 3.54 and the current share price of 55.96 USD.
When is the next dividend date for UTAH MEDICAL PRODUCTS INC (UTMD)?
The next ex-dividend date for UTAH MEDICAL PRODUCTS INC (UTMD) is December 16, 2025.
What is the market capitalization of UTMD stock?
UTAH MEDICAL PRODUCTS INC (UTMD) has a market capitalization of 179.07M USD. This makes UTMD a Micro Cap stock.
UTMD Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to UTMD. When comparing the yearly performance of all stocks, UTMD is a bad performer in the overall market: 75.73% of all stocks are doing better.
UTMD Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to UTMD. UTMD has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company.
UTMD Financial Highlights
Over the last trailing twelve months UTMD reported a non-GAAP Earnings per Share(EPS) of 3.54. The EPS decreased by -17.3% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 30.08% | ||
| ROA | 9.53% | ||
| ROE | 9.83% | ||
| Debt/Equity | 0 |